By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

We're replacing BBC Sounds outside the UK and bringing you BBC.com, a seamless way to read, watch, and listen - all in one ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Johnna Byrd began taking Zepbound to help her finish the weight loss journey she started. She never imagined it would help her stop binge drinking.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.